Anna Renglin Lindh

Anna Renglin Lindh has a diverse range of work experience. Anna is currently a Senior Business Consultant at PlantVision AB since September 2022. Prior to that, they worked as the Chief Operating Officer at Atlas Antibodies from September 2020 to August 2022. Anna also served as a Board member at Processindustriell IT & Automation – PiiA from September 2018 to July 2022.

In their previous roles, Anna worked at Recipharm where they held multiple positions including General Manager, Corporate Director Operations Development, and Site Manager. At Recipharm, they were responsible for managing product flow, business and process development, project management, and tech transfer. Anna worked at Recipharm from September 2015 to July 2020.

Anna also had noteworthy positions at Janssen Inc. as the Director of Production & Process Development, where they oversaw manufacturing operations for vaccine production, and at DSM Anti-infectives as the Manager of R&D Fermentation and DSP, where they managed fermentation and DSP processes for antibiotic manufacturing.

Throughout their career, they have gained experience in various aspects of operations, including manufacturing, process development, quality assurance/control, and project management. Anna also has additional experience in certification as a board member with StyrelseAkademien. Anna'swork experience spans over 25 years, starting from their role as QA/QC Microbiology Manager at Pharmacia in 1996.

Anna Renglin Lindh holds a PhD in Molecular Genetics from Stockholm University, which they obtained in 2004. Prior to their doctoral studies, they pursued Biotechnology at Imperial College London until 1992.